Global Dragon Blood market size was valued at USD 48.7 million in 2023. The market is projected to grow from USD 56.2 million in 2024 to USD 89.4 million by 2030, exhibiting a CAGR of 8.1% during the forecast period.
Dragon Blood refers to the red resin extracted from various plant species, primarily Dracaena and Croton trees. This biologically active substance contains potent compounds such as taspine, flavonoids, and phenolic acids that exhibit anti-inflammatory, antimicrobial, and wound-healing properties. Dragon Blood has been used in traditional medicine for centuries and is now gaining recognition in pharmaceutical applications, cosmeceuticals, and biomedical research.
The market for Dragon Blood, though niche, is expanding due to increasing demand for natural therapeutic ingredients and the growing acceptance of herbal medicine in mainstream healthcare. The rising prevalence of chronic wounds and skin conditions, coupled with the pharmaceutical industry’s shift toward plant-derived active compounds, is fueling market growth across multiple regions.
Read Full Report Here: https://www.24chemicalresearch.com/reports/204122/global-dragon-blood-forecast-market-2023-2029-60
Segmentation by Product Type
The Dragon Blood market can be divided into two key product categories based on concentration:
1. 1% Content Dragon Blood
This standardized product contains 1% active Dragon Blood resin in various carrier solutions or formulations, primarily used in cosmetics and topical applications where lower concentrations are effective.
-
Market Insight: The 1% concentration segment currently holds the majority market share due to its suitability for cosmetic applications and over-the-counter topical preparations. However, higher potency products are gaining traction as therapeutic applications expand.
-
Trend: Cosmetic manufacturers in North America and Europe prefer the 1% concentration for anti-aging creams and skin serums due to its safety profile and proven efficacy at this dosage.
2. Other Content Dragon Blood
This category includes variations from 2% up to pure Dragon Blood resin, used in pharmaceutical preparations, research applications, and specialized medical treatments.
-
Market Insight: Higher concentration Dragon Blood products are experiencing faster growth, particularly in Asia-Pacific markets where traditional medicine integration with modern healthcare is more advanced.
-
Trend: Pharmaceutical companies are increasingly exploring standardized Dragon Blood extracts with defined active compound profiles for use in clinical applications.
Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/204122/
- Top 10 Companies in the Global Soil Binders Market (2025): Industry Leaders Strengthening Erosion Control and Land Stability - August 23, 2025
- Top 10 Companies in the Boat Epoxy Primer Market (2025): Market Leaders Protecting Marine Vessels Worldwide - August 23, 2025
- Top 10 Companies in the Iodinated Contrast Industry (2025): Market Leaders Powering Diagnostic Imaging - August 23, 2025